COVID-19 Information Center
Company Updates
As COVID-19 is impacting the industry, here are some key things to know:
- Axelgaard is now experiencing a surge in orders
- Although current lead times are temporarily longer than normal, we are increasing production capacity in order to deliver your orders as quickly as possible
- Axelgaard is working closely with customers to offer immediate solutions, such as divided shipments to expedite your order
- We invite customers to explore all product offerings when ordering electrodes. Our new UltraStim® X Blue 70 mil is an excellent alternative to the PALS Blue.
- Axelgaard product lines with the letter “X” are semi-automated and thus require shorter lead times than products or custom sizes requiring more labor-intensive assembly
COVID-19 Resources
As we continue to learn more about the long-term effects of COVID-19 on patients, there is significant opportunity to educate customers about the potential benefits of NMES and TENS treatments:
- Health News: Over 75% of People Hospitalized With COVID-19 Had Symptoms 6 Months Later, Most Commonly Fatigue and Muscle Weakness
-
Webinar: A webinar entitled "Could Electrical Stimulation Improve the Recovery of People with Covid-19 Following a Prolonged ICU Stay?" is now available to watch on-line.
- The webinar features Dr. Gad Alon, PT, PhD, Emeritus Associate Professor in the University of Maryland School of Medicine, Department of Physical Therapy and Rehabilitation Science
- Clinical Literature Review: NMES and TENS Treatment for Patients Affected by COVID-19 provides more details on how Axelgaard’s high-quality electrodes may be used for therapeutic treatment of COVID-19 patients
- Clinical Literature Review: Effect of Neuromuscular Electrical Stimulation on the Recovery of People with COVID-19 Admitted to the Intensive Care Unit suggests NMES may play a role in the weaning of patients from ventilators and can be continued in the post-acute and longer-term phases of recovery. As such, NMES may be a suitable treatment modality to implement within rehabilitation pathways for COVID-19, with consideration of the practical and safety issues highlighted within this review